Lung function evaluation method for COVID-19 patients during rehabilitation period
The invention discloses a lung function evaluation method for COVID-19 patients during a rehabilitation period, which comprises the following steps: S1, regularly collecting lung function characterization data of a plurality of COVID-19 patients in different stages of the rehabilitation period to obtain lung rehabilitation time sequence data, and performing curve fitting on the lung rehabilitation time sequence data to obtain a lung function time sequence curve; S2, classifying all the COVID-19 patients based on the similarity of the lung function time sequence curve to obtain multiple groups of rehabilitation period patient clusters, and performing clustered evaluation analysis on the COVID-19 patients by using all generality; and S3, performing rehabilitation monitoring on each patient in the rehabilitation period in the rehabilitation period patient clusters to identify outlier patients, so as to realize independent evaluation management of the outlier patients by using the individual differences of the patients in the rehabilitation period. According to the method, individual evaluation management of the outlier patients is carried out by using individual differences of the patients in the rehabilitation period, and the management precision of the COVID-19 patients is improved..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 31. Dez. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
YANG FAN [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-12-31, Last update posted on www.tib.eu: 2023-10-31, Last updated: 2023-11-03 |
|---|
| Patentnummer: |
CN113854996 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA01309033X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA01309033X | ||
| 003 | DE-627 | ||
| 005 | 20231103091016.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230215s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA01309033X | ||
| 035 | |a (EPA)CN113854996 | ||
| 035 | |a (EPA)78989525 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a YANG FAN |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Lung function evaluation method for COVID-19 patients during rehabilitation period |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2021-12-31, Last update posted on www.tib.eu: 2023-10-31, Last updated: 2023-11-03 | ||
| 520 | |a The invention discloses a lung function evaluation method for COVID-19 patients during a rehabilitation period, which comprises the following steps: S1, regularly collecting lung function characterization data of a plurality of COVID-19 patients in different stages of the rehabilitation period to obtain lung rehabilitation time sequence data, and performing curve fitting on the lung rehabilitation time sequence data to obtain a lung function time sequence curve; S2, classifying all the COVID-19 patients based on the similarity of the lung function time sequence curve to obtain multiple groups of rehabilitation period patient clusters, and performing clustered evaluation analysis on the COVID-19 patients by using all generality; and S3, performing rehabilitation monitoring on each patient in the rehabilitation period in the rehabilitation period patient clusters to identify outlier patients, so as to realize independent evaluation management of the outlier patients by using the individual differences of the patients in the rehabilitation period. According to the method, individual evaluation management of the outlier patients is carried out by using individual differences of the patients in the rehabilitation period, and the management precision of the COVID-19 patients is improved. | ||
| 650 | 4 | |a G16H: Healthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data | |
| 650 | 4 | |a A61B: Diagnosis; surgery; identification (analysing biological material g01n, e.g. g01n0033480000) | |
| 650 | 4 | |a med | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a ZHENG CHUANSHENG |4 aut | |
| 700 | 0 | |a FAN WENLIANG |4 aut | |
| 700 | 0 | |a NIE ZHUANG |4 aut | |
| 700 | 0 | |a YU JIE |4 aut | |
| 700 | 0 | |a ZHANG LAN |4 aut | |
| 700 | 0 | |a SUN WENGANG |4 aut | |
| 700 | 0 | |a JIN QIANNA |4 aut | |
| 700 | 0 | |a WU FEIHONG |4 aut | |
| 700 | 0 | |a CHEN LEQING |4 aut | |
| 700 | 0 | |a YANG JINRONG |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 31. Dez. |
| 773 | 1 | 8 | |g year:2021 |g day:31 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/78989525/publication/CN113854996A1?q=CN113854996 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2021 |b 31 |c 12 |
| 951 | |a AR | ||
| 952 | |j 2021 |b 31 |c 12 | ||